EUCTR2016-003202-14-PT进行中（未招募）1 期
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Bruton’s Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination with Rituximab versus Placebo in Combination with Rituximab in Treatment Naïve Subjects with Follicular Lymphoma - PERSPECTIVE
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 440
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •* Histologically confirmed diagnosis of follicular lymphoma CD20+ (Grade 1, 2 or 3a) Ann Arbor Stage II, III or IV disease.
- •* Measurable disease
- •* Subjects 70 years of age or older; OR subjects 60-69 years of age who have one or more comorbidities.
- •* Meets one or more Groupe d'Etude des Lymphomes Folliculaire (GELF) criteria.
- •* Adequate hematologic function within protocol-defined parameters.
- •* Adequate hepatic and renal function within protocol-defined parameters.
- •* ECOG performance status score of 0-2.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 240
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 200
排除标准
- •* Transformed lymphoma
- •* Prior treatment for follicular lymphoma
- •* Central nervous system lymphoma or leptomeningeal disease
- •* Currently active, clinically significant cardiovascular disease
研究者
相似试验
进行中（未招募）
不适用
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously in Subjects with Active Rheumatoid Arthritis and Previously Treated with Biologic Anti-TNFalfa Agent(s) - NAActive rheumatoid arthritis (RA)EUCTR2005-001742-16-NLCentocor B.V.420
招募中
不适用
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to evaluate the efficacy and safety of ginkgo biloba leaf ex. inj. in Salvage treatment for Sudden Deafness PatientsDiseases of the ear and mastoid processKCT0003292Asan Medical Center68
进行中（未招募）
不适用
A clinical trial to test the safety and effectiveness of aripiprazole against placebo in children and adolescents with Tourette’s DisorderEUCTR2012-003488-23-HUOtsuka Pharmaceutical Development & Commercialization, Inc.67
未知
2 期
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Evaluate the Efficacy and Safety of Dapagliflozin as Monotherapy in Japanese Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic ControlType 2 Diabetes MellitusJPRN-jRCT2080220880AstraZeneca
进行中（未招募）
1 期
A Study to Investigate safety and how well ABBV-323 works and how safe it is in Subjects with Moderate to Severe Ulcerative Colitis Who Failed Prior Therapylcerative ColitisMedDRA version: 20.1Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 100000004856EUCTR2018-000930-37-ESAbbVie Deutschland GmbH & Co. KG60